Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$242.49 - $301.46 $779,120 - $968,590
-3,213 Reduced 41.58%
4,515 $1.11 Million
Q2 2022

Aug 15, 2022

BUY
$224.73 - $338.64 $1.2 Million - $1.81 Million
5,347 Added 224.57%
7,728 $1.91 Million
Q1 2022

May 16, 2022

BUY
$277.25 - $366.29 $660,132 - $872,136
2,381 New
2,381 $789,000
Q4 2021

Feb 14, 2022

SELL
$300.63 - $371.35 $1.19 Million - $1.47 Million
-3,961 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$310.19 - $376.2 $1.23 Million - $1.49 Million
3,961 New
3,961 $1.29 Million
Q2 2021

Aug 16, 2021

SELL
$262.71 - $351.17 $1.8 Million - $2.41 Million
-6,870 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$285.92 - $355.13 $1.96 Million - $2.44 Million
6,870 New
6,870 $2.19 Million
Q4 2020

Feb 16, 2021

SELL
$251.88 - $324.2 $942,534 - $1.21 Million
-3,742 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$255.22 - $317.0 $191,415 - $237,750
-750 Reduced 16.7%
3,742 $1.04 Million
Q2 2020

Aug 17, 2020

SELL
$141.4 - $257.09 $45,813 - $83,297
-324 Reduced 6.73%
4,492 $1.09 Million
Q1 2020

May 15, 2020

SELL
$130.51 - $196.01 $5.03 Million - $7.56 Million
-38,560 Reduced 88.9%
4,816 $699,000
Q4 2019

Feb 14, 2020

BUY
$159.31 - $223.54 $6.58 Million - $9.24 Million
41,320 Added 2009.73%
43,376 $7.4 Million
Q3 2019

Nov 14, 2019

SELL
$175.89 - $279.23 $3.05 Million - $4.85 Million
-17,360 Reduced 89.41%
2,056 $366,000
Q2 2019

Aug 14, 2019

SELL
$250.96 - $284.94 $1.2 Million - $1.36 Million
-4,784 Reduced 19.77%
19,416 $5.06 Million
Q1 2019

May 15, 2019

BUY
$276.39 - $362.25 $6.69 Million - $8.77 Million
24,200 New
24,200 $6.91 Million
Q3 2018

Nov 01, 2018

SELL
$354.53 - $449.75 $5.14 Million - $6.52 Million
-14,496 Closed
0 $0
Q2 2018

Aug 03, 2018

BUY
$278.07 - $446.21 $4.03 Million - $6.47 Million
14,496 New
14,496 $5.93 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.